Moderna (MRNA) Announces FDA Approval for mRESVIA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Moderna (MRNA) Announces FDA Approval for mRESVIA

Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)

May 31, 2024 2:00 PM EDT

mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes

CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ: MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine, to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. The approval was granted under a breakthrough therapy designation and marks the second approved mRNA product from Moderna.

"The FDA approval of... More